PRASUGREL TABLETS — Class II drug recall D-0287-2025
Ongoing recall by Golden State Medical Supply Inc., reported 2025-03-26, distributed nationwide. Failed Dissolution Specifications
| Recall number | D-0287-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Golden State Medical Supply Inc., Camarillo, CA, United States |
| Recall initiated | 2025-03-05 |
| Classified | 2025-03-20 |
| Reported by FDA | 2025-03-26 |
| Distributed | Nationwide (US) |
| Reason classes | specification failure |
| NDC | 51407-0444, 51407-0444-30, 51407-0445, 51407-0445-30 |
| Lot numbers | GS059908, GS060228, GS060709, GS061233, GS061704, GS062158, GS062405 |
| Expiration dates | 2026-04-30 |
Product
PRASUGREL TABLETS, 5 mg, 30 tablet bottles, Rx only, packaged by GSMS, Incorporated, Camarillo, CA 93012 NDC 51407-444-30
Reason for recall
Failed Dissolution Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0287-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.